Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. Abbott Labs Is A Solid Stock For Any Dividend Growth Portfolio

    Headlines

    Wed, 16 Apr 2014

    healthcare products, which operates in four segments: Diagnostics, Medical Devices, Nutritionals and Generic Pharmaceuticals . On January 22, 2014, the company reported fourth quarter earnings of $0.58 per share, which was in-line

  2. Reckitt Benckiser posts higher sales, says pharma review ongoing

    Headlines

    Wed, 16 Apr 2014

    LONDON, April 16 (Reuters) - Reckitt Benckiser Group on Wednesday reported a 4 percent rise in like-for-like sales at constant currency rates, excluding its shrinking pharmaceuticals business, and said it was on track to achieve its full-year targets.

  3. More Positive News For Lexicon, But Not The Big Announcement

    Headlines

    Tue, 15 Apr 2014

    By Stephen Simpson, CFA : Lexicon Pharmaceuticals ( LXRX ) continues to generate data on its SGLT-1/2 inhibitor LX4211 that suggest this is an effective and promising medication

  4. Teva debuts insomnia drug

    Headlines

    Tue, 15 Apr 2014

    Teva Pharmaceutical Industries ( TEVA -1.9% ) launches a generic equivalent of the insomnia drug Lunesta (eszopiclone) in the U.S. Sunovion Pharmaceuticals sells the branded product. Domestic sales are ~$850M. Post your comment!

  5. No support for Tekmira yet

    Headlines

    Tue, 15 Apr 2014

    Shares of RNA interference firm Tekmira Pharmaceuticals ( TKMR -14.5% ) continue their slide in early trading. Prices have cratered 60% since the 6x run-up peaked at $31.48

  6. Immune Pharma Tackling Orphan Disease Bullous Pemphigoid

    Headlines

    Tue, 15 Apr 2014

    By Jason Napodano : Immune Pharmaceuticals ( OTCQX:IMNP ) is developing bertilimumab, a first-in-class fully human monoclonal antibody that targets eotaxin-1, a

  7. Johnson & Johnson’s Pharma Group Leading the Way

    Video Reports

    Tue, 15 Apr 2014

    The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover.

  8. Is Now The Time To Buy Ironwood Pharmaceuticals ?

    Headlines

    Tue, 15 Apr 2014

    By Kevin Quon : Pharmaceutical companies with recently commercialized products can often ..... launched a new treatment option is Ironwood Pharmaceuticals ( IRWD ) . Ironwood Pharmaceuticals is a developing company looking to lead in

  9. Is Biogen A Value Stock Yet?

    Headlines

    Tue, 15 Apr 2014

    hometown of San Diego. San Diego-based Idec Pharmaceuticals was acquired by Biogen in 2003 and it also has ..... partnership with Carlsbad-based biotech company Isis Pharmaceuticals ( ISIS ). Founded in 1978 , Biogen Idec has

  10. Aided Again by Strong Pharma Sales, J&J Posts Solid 1Q; Raising Fair Value Estimate

    Commentary

    Tue, 15 Apr 2014

    would put the current stock price close to our estimate. The strength in J&J's most competitive division-- pharmaceuticals --reinforces our conviction in the company's wide moat. Based on the strong quarterly results, J&J slightly

« Prev12345Next »
Content Partners